Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. BFM (Berlin-Frankfurt-Münster) Relapse Study Group.
暂无分享,去创建一个
G. Henze | C. Bührer | R. Fengler | R. Hartmann | S. Schober | I. Arlt | M. Loewke
[1] S. Smith,et al. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1993, Blood.
[2] L. Robison,et al. Second neoplasms after acute lymphoblastic leukemia in childhood. , 1991, The New England journal of medicine.
[3] R Hartmann,et al. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. , 1991, Blood.
[4] R. Mulhern,et al. Late effects of antileukemic treatment. , 1988, Pediatric clinics of North America.
[5] S. George,et al. Second central nervous system prophylaxis in children with acute lymphoblastic leukemia who relapse after elective cessation of therapy. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Pullen,et al. CNS prophylaxis in acute lymphoblastic leukemia. Comparison of two methods a southwest oncology group study , 1982, Cancer.
[7] G. Henze,et al. Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. , 1993, Medical and pediatric oncology.
[8] J. Shuster,et al. Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. , 1991, Medical and pediatric oncology.
[9] R. Sabbah,et al. Effective prevention of central nervous system leukemia with intrathecal methotrexate and intrathecal methotrexate, cytosine arabinoside, and hydrocortisone in childhood acute lymphocytic leukemia. , 1990, Haematology and blood transfusion.
[10] G. Henze,et al. BFM group treatment results in relapsed childhood acute lymphoblastic leukemia. , 1990, Haematology and blood transfusion.
[11] G. Henze,et al. Risk of CNS relapse after systemic relapse of childhood acute lymphoblastic leukemia. , 1990, Haematology and blood transfusion.
[12] G. Henze,et al. Central nervous system relapse prevention in 1165 standard-risk children with acute lymphoblastic leukemia in five BFM trials. , 1990, Haematology and blood transfusion.
[13] C. Pui,et al. Cyclic combination chemotherapy for acute lymphoblastic leukemia recurring after elective cessation of therapy. , 1988, Medical and pediatric oncology.
[14] P. Dyment,et al. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study. , 1982, Blood.
[15] V. Castel,et al. [CNS prophylaxis in acute lymphoblastic leukemia (author's transl)]. , 1980, Anales espanoles de pediatria.